Suppr超能文献

住院患者的氯霉素药代动力学

Chloramphenicol pharmacokinetics in hospitalized patients.

作者信息

Koup J R, Lau A H, Brodsky B, Slaughter R L

出版信息

Antimicrob Agents Chemother. 1979 May;15(5):651-7. doi: 10.1128/AAC.15.5.651.

Abstract

The apparent body clearance of chloramphenicol was investigated in 21 hospitalized adult patients on 27 occasions. Apparent body clearance was found to be significantly lower (1.99 +/- 1.49 ml/min per kg) in patients with total serum bilirubin concentrations of >1.5 mg/100 ml than in patients with serum bilirubin concentrations of </=1.5 mg/100 ml (3.57 +/- 1.72 ml/min per kg; P < 0.001). Serum protein binding of chloramphenicol was lower in cirrhotic patients (42.2 +/- 6.8% bound) than in normal adults (53.1 +/- 5.2% bound; P < 0.001). Low binding of chloramphenicol was also found in the serum of premature neonates (32.4 +/- 8.2% bound; P < 0.001). Reduced binding in neonates implies the need for a lower therapeutic range of total chloramphenicol concentration (3.5 to 13.9 mug/ml) compared with the usual adult range (5 to 20 mug/ml). Finally, three case reports are presented which demonstrate marked abnormalities and intrasubject variation in chloramphenicol clearance.

摘要

在21例住院成年患者中进行了27次氯霉素表观体内清除率的研究。发现总血清胆红素浓度>1.5mg/100ml的患者,其氯霉素表观体内清除率显著低于血清胆红素浓度≤1.5mg/100ml的患者(分别为1.99±1.49ml/min per kg和3.57±1.72ml/min per kg;P<0.001)。肝硬化患者中氯霉素的血清蛋白结合率低于正常成年人(分别为42.2±6.8%结合和53.1±5.2%结合;P<0.001)。在早产儿血清中也发现氯霉素结合率较低(32.4±8.2%结合;P<0.001)。新生儿结合率降低意味着与通常的成人范围(5至20μg/ml)相比,氯霉素总浓度的治疗范围需要更低(3.5至13.9μg/ml)。最后,给出了3例病例报告,这些报告显示了氯霉素清除率的显著异常和个体内差异。

相似文献

1
Chloramphenicol pharmacokinetics in hospitalized patients.住院患者的氯霉素药代动力学
Antimicrob Agents Chemother. 1979 May;15(5):651-7. doi: 10.1128/AAC.15.5.651.
2
Chloramphenicol pharmacokinetics in the newborn.
Dev Pharmacol Ther. 1983;6(5):305-14. doi: 10.1159/000457331.
5
The pharmacokinetics of chloramphenicol in the neonate and young infant.
J Antimicrob Chemother. 1983 Dec;12(6):629-39. doi: 10.1093/jac/12.6.629.
6
Relationship between serum and saliva chloramphenicol concentrations.血清与唾液中氯霉素浓度的关系。
Antimicrob Agents Chemother. 1979 May;15(5):658-61. doi: 10.1128/AAC.15.5.658.
7
Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
Clin Pharmacol Ther. 1981 Sep;30(3):368-72. doi: 10.1038/clpt.1981.174.
8
Chloramphenicol disposition in infants and children.
J Pediatr. 1979 Dec;95(6):1071-7. doi: 10.1016/s0022-3476(79)80315-7.
10
Chloramphenicol dosage and pharmacokinetics in infants and children.
J Clin Pharmacol. 1983 Feb-Mar;23(2-3):106-12. doi: 10.1002/j.1552-4604.1983.tb02712.x.

引用本文的文献

6
Rapid estimation of chloramphenicol clearance in infants and children.
Clin Pharmacokinet. 1981 Jan-Feb;6(1):83-8. doi: 10.2165/00003088-198106010-00004.
8
Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.氯霉素及琥珀氯霉素的临床药代动力学
Clin Pharmacokinet. 1984 May-Jun;9(3):222-38. doi: 10.2165/00003088-198409030-00004.
9
Microdialysis sampling for determination of plasma protein binding of drugs.
Pharm Res. 1990 Oct;7(10):1077-81. doi: 10.1023/a:1015955503708.
10
Chloramphenicol clearance in typhoid fever: implications for therapy.
Indian J Pediatr. 1992 Mar-Apr;59(2):213-9. doi: 10.1007/BF02759987.

本文引用的文献

2
CHLORAMPHENICOL TOXICITY IN LIVER AND RENAL DISEASE.肝脏和肾脏疾病中的氯霉素毒性。
Arch Intern Med. 1963 Nov;112:747-54. doi: 10.1001/archinte.1963.03860050134016.
9
Chloramphenicol-associated encephalopathy.
Clin Pharmacol Ther. 1970 Mar-Apr;11(2):194-9. doi: 10.1002/cpt1970112194.
10
The 'grey toddler'. Chloramphenicol toxicity.“灰色幼儿”。氯霉素毒性。
Arch Dis Child. 1974 Mar;49(3):235-7. doi: 10.1136/adc.49.3.235.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验